Detalhe da pesquisa
1.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Lancet
; 399(10341): 2113-2128, 2022 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35644166
2.
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
Gastroenterology
; 162(7): 1891-1910, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227777
3.
Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis.
Dig Dis Sci
; 68(6): 2318-2332, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773193
4.
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
Liver Int
; 41(3): 456-463, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389788
5.
Global timing of hepatitis C virus elimination in high-income countries.
Liver Int
; 40(3): 522-529, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815353
6.
How Does Treating Chronic Hepatitis C Affect Individuals in Need of Organ Transplants in the United Kingdom?
Value Health
; 22(6): 669-676, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31198184
7.
Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations.
Value Health
; 20(6): 736-744, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577690
8.
Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.
J Med Econ
; 27(1): 566-574, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512101
9.
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Inflamm Bowel Dis
; 29(11): 1723-1729, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790041
10.
Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results.
Inflamm Bowel Dis
; 29(9): 1421-1430, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645051
11.
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.
Crohns Colitis 360
; 5(2): otad009, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36998249
12.
A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index.
J Crohns Colitis
; 17(11): 1733-1743, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37225135
13.
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.
J Gastroenterol
; 58(10): 990-1002, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490069
14.
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study.
Lancet Gastroenterol Hepatol
; 8(11): 976-989, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683686
15.
Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
Adv Ther
; 38(1): 423-440, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145648
16.
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
J Crohns Colitis
; 15(12): 2022-2030, 2021 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107013
17.
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn's Disease.
Adv Ther
; 38(5): 2339-2352, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755884
18.
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study.
Lancet Gastroenterol Hepatol
; 6(8): 616-627, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153231
19.
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy.
Infect Dis Ther
; 10(2): 763-774, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655410
20.
The Economic Value of Improved Productivity from Treatment of Chronic Hepatitis C Virus Infection: A Retrospective Analysis of Earnings, Work Loss, and Health Insurance Data.
Adv Ther
; 37(11): 4709-4719, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929647